AgonOx Inc

AgonOx, Inc. is a privately held company based in Portland, Oregon, with a team of 5 employees. Founded with the mission of developing innovative cancer therapies, AgonOx has achieved revenue of $2 million. AgonOx specializes in researching novel therapies for cancer patients, focusing on the complex relationship between T cells and tumor cells. Their research utilizes a combination of bioinformatics, in-vitro, and in-vivo testing to identify and validate promising therapeutic approaches. A key differentiator for AgonOx is its collaborative approach. Research is conducted within laboratories at the Portland Providence Cancer Center, fostering close partnerships between scientists, oncologists, surgeons, and immunologists. This collaboration has resulted in significant milestones, including two first-in-human clinical trials, with the most recent commencing in August 2023. For inquiries and further information, please visit AgonOx's website at agonox.com.